| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.926 | 3.158 | 12.936 | 5.001 | 5.679 | 4.639 | 6.875 | 7.466 | 7.035 | 6.805 |
| Total Income - EUR | 2.926 | 3.158 | 12.936 | 5.001 | 5.679 | 4.639 | 6.875 | 7.466 | 7.035 | 6.805 |
| Total Expenses - EUR | 2.490 | 2.473 | 3.124 | 4.246 | 3.959 | 4.309 | 3.602 | 5.817 | 4.865 | 5.288 |
| Gross Profit/Loss - EUR | 436 | 686 | 9.813 | 755 | 1.721 | 330 | 3.274 | 1.650 | 2.170 | 1.517 |
| Net Profit/Loss - EUR | 348 | 591 | 9.425 | 605 | 1.550 | 248 | 3.176 | 1.436 | 1.840 | 1.286 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dicuran D.a.c. Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.164 | 889 | 9.984 | 8.423 | 6.809 | 5.408 | 4.038 | 2.893 | 3.439 | 1.659 |
| Current Assets | 557 | 1.050 | 1.442 | 746 | 1.140 | 583 | 1.229 | 937 | 823 | 2.065 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 124 | 0 | 0 | 0 | 0 |
| Receivables | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 512 | 1.050 | 1.442 | 746 | 1.140 | 459 | 1.229 | 937 | 823 | 2.065 |
| Shareholders Funds | 1.606 | 1.836 | 10.649 | 1.807 | 3.322 | 1.986 | 5.118 | 3.385 | 3.783 | 3.218 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 115 | 102 | 777 | 7.362 | 4.627 | 4.004 | 149 | 445 | 479 | 506 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dicuran D.a.c. Med Srl